GO:0004930 G protein-coupled receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004930 (G protein-coupled receptor activity) is a molecular function defined as combining with an extracellular signal and transmitting it across the membrane by activating an associated heterotrimeric G-protein, promoting GDP-for-GTP exchange on the G-alpha subunit.
• GPCR activation involves ligand binding, conformational rearrangement of the receptor, and coupling to G proteins, as resolved in structural studies of receptor-G protein complexes.
• GPCRs signal through diverse downstream pathways, including the Hippo-YAP pathway, where GPCR signaling regulates YAP activity.
• Adhesion GPCRs represent a distinct class activated by mechanical or autoproteolytic mechanisms, expanding the functional repertoire of GO:0004930.
• GPCRs are implicated in numerous diseases, including inflammatory pain via GPR183, malaria parasite gametogenesis via a Plasmodium GPCR, and cancer through Hippo-YAP dysregulation.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of GPCR function in health and disease [2,4].
Description
G protein-coupled receptor activity (GO:0004930) is a fundamental molecular function that enables cells to sense extracellular signals and transduce them across the plasma membrane. This activity is executed by GPCRs, the largest family of membrane receptors, which couple ligand binding to activation of heterotrimeric G proteins by promoting GDP-for-GTP exchange on the G-alpha subunit. The importance of this function is underscored by its involvement in nearly every physiological process, from neurotransmission to immune regulation and development [1,2]. Dysregulation of GPCR signaling is linked to a wide range of diseases, including cancer, inflammatory disorders, and infectious diseases [3,6,7]. Understanding the molecular basis of GPCR activation has been a central goal in structural biology, with recent advances revealing the conformational changes and G-protein coupling mechanisms that define this activity. Moreover, GPCRs are the targets of approximately one-third of all approved drugs, making them a prime focus for therapeutic development.
G protein-coupled receptor activity At A Glance
| GO ID | GO:0004930 |
|---|---|
| GO term | G protein-coupled receptor activity |
| Ontology | molecular_function |
| Synonym | GPCR activity; G-protein coupled receptor activity; G protein linked receptor activity; orphan GPCR activity; ligand-dependent GPCR activity; EBV-induced receptor activity; Mas proto-oncogene receptor activity; RDC1 receptor activity; SREB receptor; super conserved receptor expressed in brain receptor activity |
| Major function | Transmembrane signal transduction via activation of heterotrimeric G proteins |
| Definition source | QuickGO |
| Related cellular component | Plasma membrane; heterotrimeric G-protein complex |
| Related biological process | G protein-coupled receptor signaling pathway; signal transduction |
What Is GO:0004930?
According to the Gene Ontology, GO:0004930 (G protein-coupled receptor activity) is defined as the molecular function of combining with an extracellular signal and transmitting that signal across the membrane by activating an associated G-protein; this activity promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. In essence, a GPCR acts as a guanine nucleotide exchange factor (GEF) for its cognate G-alpha subunit upon ligand binding, initiating downstream signaling cascades.
Why Is G protein-coupled receptor activity Important in Cell Biology?
GO:0004930 is critically important because GPCRs mediate the majority of cellular responses to hormones, neurotransmitters, and environmental cues, and they are the largest family of drug targets [1,4]. Structural and functional studies have revealed that GPCR activation involves conserved conformational changes that enable G-protein coupling, providing a mechanistic basis for understanding signal transduction. Beyond classical signaling, GPCRs crosstalk with receptor tyrosine kinases to modulate synaptic plasticity, highlighting their integrative role in neuronal function. The Hippo-YAP pathway is regulated by GPCR signaling, linking this activity to cell proliferation and organ size control. Adhesion GPCRs add another layer of complexity, with unique activation mechanisms that respond to mechanical forces. In disease contexts, GPCRs such as GPR183 drive inflammatory pain through macrophage-derived CCL22, and a Plasmodium GPCR controls gametogenesis via PKG-mediated signaling. Thus, understanding GO:0004930 is essential for both basic biology and therapeutic intervention.
• GPCRs are the largest family of membrane receptors and the targets of ~34% of approved drugs.
• They regulate fundamental processes including neurotransmission, immune responses, and development [1,2].
• GPCR signaling controls the Hippo-YAP pathway, influencing cell proliferation and cancer.
• Adhesion GPCRs mediate cell-cell and cell-matrix interactions with unique activation mechanisms.
• GPR183 activation in macrophages promotes inflammatory pain via CCL22 secretion.
• A Plasmodium GPCR is essential for gametogenesis and transmission of malaria.
• GPCRs can crosstalk with receptor tyrosine kinases to modulate synaptic plasticity.
• Structural studies of GPCR-G protein complexes inform rational drug design [1,8].
• Lipid-mediated activation of receptors like GPR55 reveals novel regulatory modes.
• CRISPR screens and models enable systematic dissection of GPCR function in disease [2,4].
Molecular Mechanism of G protein-coupled receptor activity
Ligand binding and receptor activation
In simple terms: A signal molecule binds to the receptor on the outside of the cell, causing the receptor to change shape.
GPCR activation begins with the binding of an extracellular ligand to the receptor's orthosteric site, which stabilizes an active conformation. This involves outward movement of transmembrane helix 6 and rearrangement of the conserved DRY motif, as detailed in structural studies of agonist-bound receptors. For adhesion GPCRs, activation can occur through autoproteolysis or mechanical force, revealing diverse activation modes. Lipid-mediated activation, as shown for GPR55, further expands the repertoire of activation mechanisms.
G-protein coupling and nucleotide exchange
In simple terms: The activated receptor acts like a switch to turn on a G protein inside the cell.
The active receptor engages the heterotrimeric G protein (G-alpha, G-beta, G-gamma) and promotes the release of GDP from G-alpha, allowing GTP to bind. This nucleotide exchange is the defining biochemical event of GO:0004930. Structural snapshots of receptor-G protein complexes have revealed the conformational changes in G-alpha that accompany nucleotide exchange, including displacement of the P-loop and alpha5 helix.
Downstream signaling and effector modulation
In simple terms: Once turned on, the G protein triggers a cascade of signals inside the cell.
GTP-bound G-alpha dissociates from G-beta-gamma and modulates effectors such as adenylyl cyclase, phospholipase C, and ion channels. These pathways regulate second messenger levels and kinase cascades. GPCR signaling can also intersect with the Hippo-YAP pathway, where G-alpha subunits regulate YAP phosphorylation and activity. Additionally, crosstalk with receptor tyrosine kinases modulates synaptic plasticity, as shown for GPCR-RTK interactions.
Regulation by lipids and allosteric modulators
In simple terms: Fats and other molecules can fine-tune how well the receptor works.
Lipids such as lysophosphatidylinositol can act as orthosteric or allosteric ligands for certain GPCRs. For GPR55, structural studies revealed a lipid-binding pocket and lipid-mediated activation mechanism. Allosteric modulators can also stabilize active or inactive states, offering opportunities for selective pharmacological targeting.
Receptor desensitization and internalization
In simple terms: After signaling, the receptor is turned off and brought inside the cell to reset the system.
Following activation, GPCRs are phosphorylated by GRKs and bind arrestins, which uncouple the receptor from G proteins and promote internalization. This feedback regulation is essential for maintaining signaling fidelity. The dynamic nature of GPCR activation and desensitization is captured in structural and functional studies [1,5].
Key Genes Involved in GO:0004930 G protein-coupled receptor activity
The following genes encode representative GPCRs and G-protein subunits that are central to GO:0004930, with diverse roles in physiology and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADRB2 | Beta-2 adrenergic receptor; couples to Gs | Model for GPCR activation and drug discovery |
| DRD2 | Dopamine receptor D2; couples to Gi | Target for antipsychotics; studied in synaptic plasticity |
| GPR183 | EBI2; receptor for 7α,25-dihydroxycholesterol | Drives inflammatory pain via macrophage CCL22 |
| GPR55 | Lipid-activated receptor | Structural basis for lipid-mediated activation |
| ADGRG1 | Adhesion GPCR G1 | Mechanisms of adhesion GPCR activation |
| ADGRG2 | Adhesion GPCR G2 | Role in mechanotransduction |
| LGR5 | Leucine-rich repeat-containing GPCR 5 | Stem cell marker; Hippo-YAP crosstalk |
| FZD1 | Frizzled class receptor 1 | Wnt signaling; GPCR activity |
| GNAS | G-alpha s subunit | Nucleotide exchange and cAMP signaling |
| GNAI1 | G-alpha i subunit | Inhibits adenylyl cyclase |
| GNAQ | G-alpha q subunit | Activates phospholipase C |
| ARRB1 | Beta-arrestin 1 | Desensitization and internalization |
| GRK2 | G protein-coupled receptor kinase 2 | Phosphorylates activated GPCRs |
| CXCR4 | C-X-C chemokine receptor type 4 | Cancer metastasis and HIV entry |
| CCR5 | C-C chemokine receptor type 5 | HIV co-receptor; drug target |
| PTGER2 | Prostaglandin E receptor 2 | Inflammation and pain |
| PBGPCR | Plasmodium berghei GPCR | Gametogenesis via PKG signaling |
How Is G protein-coupled receptor activity Regulated?
GPCR activity is regulated at multiple levels. Receptor phosphorylation by GRKs and subsequent arrestin binding desensitize the receptor and promote internalization. Allosteric modulators and lipids can fine-tune receptor activation, as shown for GPR55. Additionally, crosstalk with receptor tyrosine kinases modulates GPCR signaling in synaptic plasticity. The Hippo-YAP pathway is regulated by GPCR signaling, linking receptor activity to transcriptional programs.
G protein-coupled receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPR183 | Inflammatory pain | Knockout mouse; macrophage-specific KO |
| LGR5 | Cancer (colorectal) | Knock-in reporter; overexpression |
| CXCR4 | Cancer metastasis | Point mutation (e.g., gain-of-function) |
| PBGPCR | Malaria transmission | Knockout in Plasmodium berghei |
| ADGRG1 | Neurodevelopmental disorders | Knockout and point mutation models |
GPCRs in cancer
GPCR signaling regulates the Hippo-YAP pathway, which controls cell proliferation and organ size; dysregulation contributes to cancer. For example, LGR5 and FZD1 are GPCRs that modulate YAP activity, and their aberrant expression is associated with tumorigenesis. Chemokine receptors such as CXCR4 and CCR5 are implicated in cancer metastasis and are targets for therapeutic intervention.
GPCRs in inflammatory and neuropathic pain
GPR183 (EBI2) activation in macrophages promotes CCL22 secretion, which initiates inflammatory pain. This highlights the role of GPCRs in immune-neuronal crosstalk and suggests GPR183 as a potential target for pain management.
GPCRs in infectious disease
A Plasmodium berghei GPCR modulates gametogenesis via a PKG-mediated signaling cascade, which is essential for malaria transmission. Targeting this GPCR could block parasite development in the mosquito vector.
GPCRs in neurological disorders
GPCR crosstalk with receptor tyrosine kinases modulates synaptic plasticity, a process underlying learning and memory. Dysregulation of this crosstalk is implicated in neurodevelopmental and neurodegenerative conditions.
From G protein-coupled receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GPCR X affect downstream signaling? | Knockout cell line (e.g., HEK293) |
| Does a specific point mutation alter ligand binding? | Point mutation knock-in via CRISPR |
| Can we track receptor localization in live cells? | Tagged knock-in (e.g., GFP) |
| Does overexpression of GPCR Y drive proliferation? | Overexpression stable cell line |
| Which GPCRs regulate a phenotype in a genome-wide manner? | CRISPR library screening |
| Does GPCR Z mediate inflammatory pain in vivo? | Conditional knockout mouse |
How to Study the G protein-coupled receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of receptor-G protein complex | Mechanistic studies of activation |
| cAMP assay | Intracellular cAMP levels | Gs/Gi coupling |
| GTPγS binding | G protein activation | Receptor agonist efficacy |
| CRISPR knockout screen | Gene essentiality for a phenotype | Discovery of GPCR pathways |
| RNA-seq | Transcriptional changes | Downstream signaling |
| BRET/FRET | Protein-protein interactions | Receptor-G protein coupling |
| Behavioral testing | Pain or cognitive responses | In vivo GPCR function |
| Phosphoproteomics | Kinase signaling changes | GPCR crosstalk |
Structural biology (cryo-EM and X-ray crystallography)
Cryo-EM and X-ray crystallography have resolved structures of GPCRs in active and inactive states, revealing conformational changes and G-protein coupling interfaces. These methods are essential for understanding the molecular basis of GO:0004930 [1,8].
Functional assays (cAMP, calcium, GTPγS)
Second messenger assays such as cAMP accumulation, calcium mobilization, and GTPγS binding measure GPCR activity and G-protein coupling. These are standard for characterizing receptor function and drug efficacy.
CRISPR screening and genomics
Genome-wide CRISPR knockout screens can identify GPCRs and downstream components required for specific cellular phenotypes. This approach is powerful for discovering novel GPCR functions in disease models.
In vivo models and behavioral assays
Knockout and transgenic mouse models are used to study GPCR roles in physiology and behavior, such as inflammatory pain and synaptic plasticity. Parasite models like Plasmodium berghei enable study of GPCRs in infectious disease.
How CRISPR Can Be Used to Study GO:0004930 G protein-coupled receptor activity
Knockout
CRISPR knockout of GPCR genes in cell lines or animal models enables loss-of-function studies to determine causality in signaling pathways and disease phenotypes [2,4]. For example, knockout of GPR183 in macrophages can test its role in inflammatory pain.
Point Mutation
CRISPR-mediated point mutations can mimic disease-associated variants or alter ligand binding sites to dissect receptor function at the molecular level. This is particularly useful for studying constitutively active or inactive GPCR mutants.
Knock-in
Knock-in of tagged GPCRs (e.g., GFP, HA) allows real-time tracking of receptor localization and trafficking in live cells. Knock-in of human GPCRs into model organisms can humanize drug testing.
Overexpression
Overexpression of wild-type or mutant GPCRs in cell lines is used to study gain-of-function effects, such as enhanced proliferation via YAP activation. This approach is valuable for drug screening and signaling studies.
How EDITGENE Supports G protein-coupled receptor activity Research
Researchers studying G protein-coupled receptor activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of GPCRs and their downstream effectors.
Contact EDITGENE today to design your custom CRISPR model for G protein-coupled receptor activity research.
Frequently Asked Questions About G protein-coupled receptor activity
What is GO:0004930?
GO:0004930 is the Gene Ontology term for G protein-coupled receptor activity, defined as combining with an extracellular signal and transmitting it across the membrane by activating an associated G-protein, promoting GDP-for-GTP exchange on the G-alpha subunit.
What genes are involved in G protein-coupled receptor activity?
Genes encoding GPCRs (e.g., ADRB2, DRD2, GPR183, LGR5) and heterotrimeric G-protein subunits (e.g., GNAS, GNAI1, GNAQ) are central to this activity [1,3,6].
How does GPCR activation work?
Ligand binding stabilizes an active receptor conformation that couples to G proteins, triggering GDP release and GTP binding on G-alpha, which then modulates downstream effectors.
What diseases are associated with GPCRs?
GPCRs are implicated in cancer, inflammatory pain, infectious diseases like malaria, and neurological disorders [3,6,7].
What are adhesion GPCRs?
Adhesion GPCRs are a subfamily with large extracellular domains that mediate cell-cell and cell-matrix interactions and can be activated by mechanical forces or autoproteolysis.
How can CRISPR be used to study GPCRs?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of GPCR function in signaling and disease [2,4].
What is the role of GPR183 in pain?
GPR183 activation in macrophages promotes CCL22 secretion, which initiates inflammatory pain.
How does GPCR signaling regulate the Hippo pathway?
GPCR signaling through G-alpha subunits modulates YAP phosphorylation and activity, linking receptor activity to cell proliferation.
What is the structural basis of GPCR activation?
Structures of agonist-bound GPCR-G protein complexes reveal conserved conformational changes, including TM6 movement and G-alpha helix displacement.
Can GPCRs be targeted for malaria treatment?
A Plasmodium GPCR is essential for gametogenesis; targeting it could block malaria transmission.
Conclusion
GO:0004930 (G protein-coupled receptor activity) represents a cornerstone of cellular signal transduction, with profound implications for physiology and disease. Structural and functional studies have illuminated the molecular choreography of receptor activation and G-protein coupling. The diversity of GPCRs and their involvement in cancer, pain, and infectious diseases underscores their therapeutic potential [3,6,7]. CRISPR-based models are indispensable for causal validation of GPCR function, and EDITGENE offers a comprehensive suite of services to support such research.
References
- 1. Weis WI et al.. 2018. The Molecular Basis of G Protein-Coupled Receptor Activation.. Annu Rev Biochem 87:897-919 PMID: 29925258
- 2. Lao-Peregrin C et al.. 2024. Synaptic plasticity via receptor tyrosine kinase/G-protein-coupled receptor crosstalk.. Cell Rep 43(1):113595 PMID: 38117654
- 3. Yu FX et al.. 2012. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.. Cell 150(4):780-91 PMID: 22863277
- 4. Szwabowski GL et al.. 2024. G Protein-Coupled Receptor-Ligand Pose and Functional Class Prediction.. Int J Mol Sci 25(13) PMID: 38999982
- 5. Vizurraga A et al.. 2020. Mechanisms of adhesion G protein-coupled receptor activation.. J Biol Chem 295(41):14065-14083 PMID: 32763969
- 6. Qi Z et al.. 2023. Activation of G-protein-coupled receptor 183 initiates inflammatory pain via macrophage CCL22 secretion.. Eur J Pharmacol 954:175872 PMID: 37353188
- 7. Wang PP et al.. 2022. A G-Protein-Coupled Receptor Modulates Gametogenesis via PKG-Mediated Signaling Cascade in Plasmodium berghei.. Microbiol Spectr 10(2):e0015022 PMID: 35404079
- 8. Claff T et al.. 2025. Structural basis for lipid-mediated activation of G protein-coupled receptor GPR55.. Nat Commun 16(1):1973 PMID: 40000629
